Role of catecholamine oxidation in sudden cardiac death

Fundamental and Clinical Pharmacology

Volumn 24, Issue 5, 2010, Pages 539-546

  Dhalla, Naranjan S ^a   Adameova, Adriana ^a,b   Kaur, Meera ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b Physics and Informatics   (Slovakia)

Author keywords

adrenochrome; arrhythmias; coronary spasm; intracellular Ca 2+ overload; myocardial cell damage

Indexed keywords

ADRENALIN; ADRENOCHROME; ALPHA ADRENERGIC RECEPTOR; ALPHA TOCOPHEROL; ASCORBIC ACID; BETA ADRENERGIC RECEPTOR; CALCIUM; CALCIUM CHANNEL; CATION CHANNEL; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; FATTY ACID; ISOPRENALINE; NORADRENALIN; OXYGEN RADICAL; PHOSPHOLIPASE; PROTEINASE; QUININE; RETINOL; ZINC SULFATE;

ADRENERGIC SYSTEM; ARRHYTHMOGENESIS; ATRIOVENTRICULAR BLOCK; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CARDIOMYOPATHY; CARDIOTOXICITY; CATECHOLAMINE BLOOD LEVEL; CELL DAMAGE; CELL MEMBRANE; CONGESTIVE HEART FAILURE; CORONARY ARTERY CONSTRICTION; CORONARY ARTERY SPASM; CYCLIC AMP BLOOD LEVEL; FATTY ACID BLOOD LEVEL; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART CONTRACTION; HEART DEATH; HEART MUSCLE ISCHEMIA; HEART RHYTHM; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE BIGEMINY; HEART VENTRICLE CONTRACTION; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE TACHYCARDIA; HYPERTENSION; INTOXICATION; ISCHEMIC HEART DISEASE; MORTALITY; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PHOSPHATE DEFICIENCY; PRIORITY JOURNAL; REVIEW; SARCOPLASMIC RETICULUM; SMOOTH MUSCLE; SUDDEN DEATH;

ANIMALS; ARRHYTHMIAS, CARDIAC; CALCIUM; CATECHOLAMINES; DEATH, SUDDEN, CARDIAC; HEART VENTRICLES; HUMANS; OXIDATION-REDUCTION; OXIDATIVE STRESS;

EID: 77956972089     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2010.00836.x     Document Type: Review

References (67)

1. Wolf C.M., Berul C.I. Molecular mechanisms of inherited arrhythmias. Curr. Genomics (2008) 9 160 168.
2. Kurokawa J., Abriel H. Neurohormonal regulation of cardiac ion channels in chronic heart failure. J. Cardiovasc. Pharmacol. (2009) 54 98 105.
3. Rodriguez-Calvo M.S., Brion M., Allegue C. et al. Molecular genetics of sudden cardiac death. Forensic Sci. Int. (2008) 182 1 12.
4. Scorza F.A., Albuquerque M.D., Arida R.M. et al. Benefits of sunlight: vitamin D deficiency might increase the risk of sudden expected death in epilepsy. Med. Hypotheses (2010) 74 158 161.
5. Maldonado C., Soni C.V., Todnem N.D. et al. Hyperhomocysteinemia and sudden cardiac death: potential arrhythmogenic mechanisms. Curr. Vasc. Pharmacol. (2010) 8 64 74.
6. Cheitlin M.D., MacGregor J. Congenital anomalies of coronary arteries: role in the pathogenesis of sudden cardiac death. Herz (2009) 34 268 279.
7. Arshad A., Mandava A., Kamath G. et al. Sudden cardiac death and the role of medical therapy. Prog. Cardiovasc. Dis. (2008) 50 420 438.
8. Makkar K.M., Sanoski C.A., Spinler S.A. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias. Pharmacotherapy (2009) 29 31 48.
9. Van Tassell B.W., Radwanski P., Movsesian M. et al. Combination therapy with β-adrenergic receptor antagonists and phosphodiesterase inhibitors for chronic heart failure. Pharmacotherapy (2008) 28 1523 1530.
10. Zhao Y.T., Chen Q., Sun Y.X. et al. Prevention of sudden cardiac death with omega-3 fatty acids in patients with coronary heart disease: a meta-analysis of randomized controlled trials. Ann. Med. (2009) 41 301 310.
11. Majmudar M.D., Tompkins C., Bachmann J.M. et al. Effects of lipid-altering therapies on ventricular arrhythmias and sudden cardiac death. Cardiol. Rev. (2009) 17 60 69.
12. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. J. Am. Coll. Cardiol. (1988) 12 3A 13A.
13. Erickson J.R., Anderson M.E. CaMKII and its role in cardiac arrhythmia. J. Cardiovasc. Electrophysiol. (2008) 19 1332 1336.
14. Chelu M.G., Wehrens X.H. Sarcoplasmic reticulum calcium leak and cardiac arrhythmias. Biochem. Soc. Trans. (2007) 35 952 956.
15. Thomas N.L., George C.H., Williams A.J. et al. Ryanodine receptor mutations in arrhythmias: advances in understanding the mechanisms of channel dysfunction. Biochem. Soc. Trans. (2007) 35 946 951.
16. Blayney L.M., Lai F.A. Ryanodine receptor-mediated arrhythmias and sudden cardiac death. Pharmacol. Ther. (2009) 123 151 177.
17. Rona G. Catecholamine cardiotoxicity. J. Mol. Cell. Cardiol. (1985) 17 291 306.
18. Ostadal B., Pelouch V., Ostadalova I. et al. Structural and biochemical remodeling in catecholamine-induced cardiomyopathy: comparative and ontogenetic aspects. Mol. Cell. Biochem. (1995) 147 83 88.
19. Dhalla N.S., Dent M.R., Arneja A.S. Pathogenesis of catecholamine-induced cardiomyopathy, in : Acosta D. Jr. (Ed Cardiovascular toxicology, 4th edn, Informa Healthcare USA Inc., New York, 2008, pp. 207 262.
20. Adameova A., Abdellatif Y., Dhalla N.S. Role of the excessive amounts of circulating catecholamines and glucocorticoids in stress-induced heart disease. Can. J. Physiol. Pharmacol. (2009) 87 493 514.
21. Singal P.K., Beamish R.E., Dhalla N.S. Potential oxidative pathways of catecholamines in the formation of lipid peroxides and genesis of heart disease, in : Spitzer J.J. (Ed Advances in experimental medical biology, Vol. 161, Plenum Publishing Corporation, New York, 1983, pp. 391 401.
22. Green D.E., Ritter D. Adrenaline and adrenochrome. Biochem. J. (1937) 31 596 616.
23. Dhalla K.S., Ganguly P.K., Rupp H. et al. Measurement of adrenolutin as an oxidation product of catecholamines in plasma. Mol. Cell. Biochem. (1989) 87 85 92.
24. Schimpf R., Veltmann C., Wolpert C. et al. Channelopathies: Brugada syndrome, long QT syndrome, short QT syndrome, and CPVT. Herz (2009) 34 281 288.
25. Dhalla N.S., Elimban V., Rupp H. et al. Role of calcium in cardiac cell damage and dysfunction, in : Sperelakis N. (Ed Physiology and pathophysiology of the heart, Kluwer Academic Publishers, Boston, 1995, pp. 605 623.
26. Dhalla N.S., Temsah R.M., Netticadan T. et al. Calcium overload in ischemia/reperfusion injury, in : Sperelakis N., Kurachi Y., Terzic A., Cohen M. (Eds Heart physiology and pathophysiology, 4th edn, Academic Press, San Diego, 2001, pp. 949 965.
27. Schaffer S.W., Tan B.H. Effect of calcium depletion and calcium paradox on myocardial energy metabolism. Can. J. Physiol. Pharmacol. (1985) 63 1384 1391.
28. Minezaki K.K., Suleiman M.-S., Chapman R.A. Changes in mitochondrial function induced in isolated guinea-pig ventricular myocytes by calcium overload. J. Physiol. (1994) 476 459 471.
29. Bhagat B., Rao P.S., Dhalla N.S. Role of catecholamines in the genesis of arrhythmias. Adv. Myocardiol. (1980) 2 117 132.
30. 2+-induced ventricular tachycardia in the intact pig heart. Basic Res. Cardiol. (1981) 75 772 779.
31. Podzuweit T., Els D., McCarthy J. Cyclic AMP mediated arrhythmias induced in the ischaemic pig heart. Basic Res. Cardiol. (1981) 76 443 448.
32. Cordor D.W., Heyliger C.E., Beamish R.E. et al. Defects in the adrenergic receptor-adenylate cyclase system during the development of catecholamine-induced cardiomyopathy. Am. Heart J. (1984) 107 537 542.
33. Panagia V., Pierce G.N., Dhalla K.S. et al. Adaptive changes in subcellular calcium transport during catecholamine-induced cardiomyopathy. J. Mol. Cell. Cardiol. (1985) 17 411 420.
34. 2+ transport. Arch. Biochem. Biophys. (2001) 387 85 92.
35. Dhalla N.S., Dzurba A., Pierce G.N. et al. Membrane changes in myocardium during catecholamine-induced pathological hypertrophy. Persp. Cardiovasc. Res. (1983) 7 527 534.
36. Dhalla N.S., Yates J.C., Lee S.L. et al. Functional and subcellular changes in the isolated rat heart perfused with oxidized isoproterenol. J. Mol. Cell. Cardiol. (1978) 10 31 41.
37. Takeo S., Fliegel L., Beamish R.E. et al. Effect of adrenochrome on rat heart sarcolemmalATPase activities. Biochem. Pharmacol. (1980) 29 559 564.
38. 2+ transport due to excess catecholamines. Cardiovasc. Drugs Ther. (1996) 10 231.
39. Takeo S., Taam G.M.L., Beamish R.E. et al. Effects of adrenochrome on calcium accumulating and ATPase activities on the rat heart microsomes. J. Pharmacol. Exp. Ther. (1980) 214 688 693.
40. Takeo S., Taam G.M.L., Beamish R.E. et al. Effect of adrenochrome on calcium accumulation by heart mitochondria. Biochem. Pharmacol. (1981) 30 157 163.
41. Taam G.M.L., Takeo S., Ziegelhoffer A. et al. Effect of adrenochrome on adenine nucleotides and mitochondrial oxidative phosphorylation in rat heart. Can. J. Cardiol. (1986) 2 88 93.
42. Yates J.C., Dhalla N.S. Induction of necrosis and failure in the isolated perfused rat heart with oxidized isoproterenol. J. Mol. Cell. Cardiol. (1975) 7 807 816.
43. Steen E.M., Noronha-Dutra A.A., Woolf N. The response of isolated rat heart cells to cardiotoxic concentrations of isoprenaline. J. Pathol. (1982) 137 167 176.
44. Severin S., Sartore S., Schiaffino S. Direct toxic effects of isoproterenol on cultured muscle cells. Experentia (1977) 33 1489 1490.
45. Yates J.C., Beamish R.E., Dhalla N.S. Ventricular dysfunction and necrosis produced by adrenochrome metabolite of epinephrine: relation to pathogenesis of catecholamine cardiomyopathy. Am. Heart J. (1981) 102 210 221.
46. Yates J.C., Taam G.M.L., Singal P.K. et al. Protection against adrenochrome induced myocardial damage by various pharmacological intervention. Br. J. Exp. Pathol. (1980) 61 242 255.
47. Yates J.C., Taam G.M.L., Singal P.K. et al. Modification of adrenochrome-induced cardiac contractile failure and cell damage by changes in cation concentrations. Lab. Invest. (1980) 43 316 326.
48. Singal P.K., Dhillon K.S., Beamish R.E. et al. Myocardial cell damage and cardiovascular changes due to I.V. infusion of adrenochrome in rats. Br. J. Exp. Pathol. (1982) 63 167 176.
49. Waldenstrom A.P., Hjalmarson A.C., Thomell L. A possible role of noradrenaline in the development of myocardial infarction. An experimental study in the isolated rat hearts. Am. Heart J. (1978) 95 43 51.
50. Mosinger B., Stejskal J., Tutterova M. et al. Myocardial lesions induced by natural catecholamines in vitro. Eur. J. Cardiol. (1978) 6 389 402. (Pubitemid 8258605)
51. Ostadal B., Poupa O. Occlusion of coronary vessels after administration of isoprenoline, adrenaline and noradrenalin. Physiol. Bohemoslov. (1967) 16 116 119.
52. Beamish R.E., Karmazyn M., Panagia V. et al. Mechanisms of coronary spasm in stress-induced heart disease, in : Stephens N.L. (Ed Smooth muscle contraction, Marcel Dekker Inc, New York, 1984, pp. 537 550.
53. Karmazyn M., Beamish R.E., Dhalla N.S. Involvement of calcium in coronary vasoconstriction due to prolonged hypoxia. Am. Heart J. (1984) 107 293 297.
54. Karmazyn M., Beamish R.E., Fliegel L. et al. Adrenochrome induced coronary artery constriction in the rat heart. J. Pharmacol. Exp. Ther. (1981) 219 225 230.
55. Beamish R.E., Dhalla N.S. Involvement of catecholamines in coronary spasm under stressful conditions, in : Beamish R.E., Singal P.K., Dhalla N.S. (Eds Stress and heart disease, Martinus Nijhoff, Boston, 1985, pp. 129 141.
56. Dhalla N.S., Temsah R.M., Netticadan T. Role of oxidative stress in cardiovascular diseases. J. Hypertens. (2000) 18 655 673.
57. Lown B. Clinical management of ventricular arrhythmias. Hosp. Pract. (1982) 17 73 86.
58. Singal P.K., Kapur N., Dhillon K.S. et al. Role of free radicals in catecholamine-induced cardiomyopathy. Can. J. Physiol. Pharmacol. (1982) 60 1390 1397.
59. Singal P.K., Kapur N., Beamish R.E. et al. Antioxidant protection against epinephrine-induced arrhythmias, in : Beamish R.E., Singal P.K., Dhalla N.S. (Eds Stress and heart disease, Martinus Nijhoff, Boston, 1985, pp. 190 201.
60. Barta J., Sanganalmath S.K., Kumamoto H. et al. Antiplatelet agents sarpogrelate and cilostazol affect experimentally-induced ventricular arrhythmias and mortality. Cardiovasc. Toxicol. (2008) 8 127 135.
61. Sethi R., Adameova A., Dhalla K.S. et al. Modification of epinephrine-induced arrhythmias by N-acetyl L-cysteine and vitamin E. J. Cardiovasc. Pharmacol. Ther. (2009) 14 134 142.
62. Sethi R., Rehsia N.S., Jindal K. et al. Antiarrhythmic effects of some antioxidant vitamins in rats injected with epinephrine. Cardiovasc. Toxicol. (2009) 9 177 184.
63. Beamish R.E., Dhillon K.S., Singal P.K. et al. Protective effect of sulfinpyrazone against catecholamine metabolite adrenochrome induced arrhythmias. Am. Heart J. (1981) 102 149.
64. The Anturane Reinfarction Trial Research Group. Sulfinpyrazone in the prevention of cardiac death after myocardial infarction. N. Engl. J. Med. (1980) 302 250 256.
65. Singal P.K., Yates J.C., Beamish R.E. et al. Influence of reducing agents on adrenochrome-induced changes in the heart. Arch. Pathol. Lab. Med. (1981) 105 664 669.
66. Rouleau J.L., Pitt B., Dhalla N.S. et al. Prognostic importance of the oxidized product of catecholamines, adrenolutin, in patients with severe heart failure. Am. Heart J. (2003) 145 926 932.
67. Wijeysundera H.C., Hansen M.S., Stanton E. et al. Neurohormones and oxidative stress in non-ischemic cardiomyopathy: relationship to survival and the effect of treatment with amlodipine. Am. Heart J. (2003) 146 291 297.